4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001209191-07-071075
CIK 0001382911operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 6:39 PM ET
Size
22.1 KB
Accession
0001209191-07-071075
Insider Transaction Report
Form 4
TOLLEFSON GARY D
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2007-12-17$0.60/sh+15,000$9,000→ 15,000 total - Sale
Common Stock
2007-12-17$14.33/sh−2,000$28,660→ 2,000 total - Sale
Common Stock
2007-12-17$14.15/sh−1,000$14,150→ 14,000 total - Sale
Common Stock
2007-12-17$14.27/sh−4,000$57,080→ 6,000 total - Exercise/Conversion
Stock Option (right to buy)
2007-12-17−15,000→ 840,883 totalExercise: $0.60Exp: 2015-05-26→ Common Stock (15,000 underlying) - Sale
Common Stock
2007-12-17$14.26/sh−3,000$42,780→ 10,000 total
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/13/2007.
- [F2]674,216 remaining shares of common stock subject to the option are immediately exercisable. 166,667 shares of common stock subject to the option become exercisable on 01/01/2008. As of December 19, 2007, 550,588 of the remaining shares of common stock subject to the option are vested, and approximately 18,143 shares of common stock subject to the option vest on the first date of each month until April 1, 2009.
- [F3]Not applicable to this transaction.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 6:39 PM ET
- Size
- 22.1 KB